PCRX Share Price

Open 34.30 Change Price %
High 34.60 1 Day -0.35 -1.01
Low 33.85 1 Week -0.20 -0.58
Close 34.20 1 Month -2.10 -5.79
Volume 703749 1 Year -0.45 -1.30
52 Week High 58.95
52 Week Low 29.95
PCRX Important Levels
Resistance 2 34.90
Resistance 1 34.61
Pivot 34.22
Support 1 33.79
Support 2 33.50
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
ASTI 0.00 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
DEST 2.38 48.75%
HAUP 0.08 33.33%
SCHS 0.04 33.33%
SYNT 24.30 27.23%
SYNT 24.30 27.23%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PGRX 0.05 25.00%
More..
NASDAQ USA Top Losers Stocks
CAFI 0.00 -100.00%
DEER 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX)

PCRX Technical Analysis 5
As on 17th Oct 2017 PCRX Share Price closed @ 34.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 41.40 & Strong Sell for SHORT-TERM with Stoploss of 36.71 we also expect STOCK to react on Following IMPORTANT LEVELS.
PCRX Target for October
1st Target up-side 40.03
2nd Target up-side 41.77
3rd Target up-side 43.51
1st Target down-side 35.07
2nd Target down-side 33.33
3rd Target down-side 31.59
PCRX Other Details
Segment EQ
Market Capital 512069248.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.pacira.com
PCRX Address
PCRX
5 Sylvan Way
Suite 100
Parsippany, NJ 07054
United States
Phone: 973-254-3560
PCRX Latest News
Interactive Technical Analysis Chart Pacira Pharmaceuticals, Inc. ( PCRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pacira Pharmaceuticals, Inc.
PCRX Business Profile
Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control. Its products include EXPAREL (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic; DepoCyt(e) (cytarabine liposome injection) is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine; and DepoDur (morphine sulfate extended-release liposome injection) is an extended-release, injectable formulation of morphine.